Neogen (NEOG) Free Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 27.44% |
| Nov 30, 2025 | -12.94% |
| Aug 31, 2025 | -21.33% |
| May 31, 2025 | -54.50% |
| Feb 28, 2025 | -23.10% |
| Nov 30, 2024 | 17.26% |
| Aug 31, 2024 | -39.41% |
| May 31, 2024 | -32.73% |
| Feb 29, 2024 | -69.35% |
| Nov 30, 2023 | -22.37% |
| Aug 31, 2023 | -20.48% |
| May 31, 2023 | 29.60% |
| Feb 28, 2023 | -34.65% |
| Nov 30, 2022 | -67.65% |
| Aug 31, 2022 | -31.31% |
| May 31, 2022 | -10.29% |
| Feb 28, 2022 | -14.95% |
| Nov 30, 2021 | 16.50% |
| Aug 31, 2021 | 5.42% |
| May 31, 2021 | 28.13% |
| Feb 28, 2021 | -2.92% |
| Nov 30, 2020 | 10.90% |
| Aug 31, 2020 | 40.77% |
| May 31, 2020 | 18.80% |
| Feb 29, 2020 | 15.39% |
| Nov 30, 2019 | -0.63% |
| Aug 31, 2019 | 16.86% |
| May 31, 2019 | 125.54% |
| Feb 28, 2019 | 7.87% |
| Nov 30, 2018 | 33.38% |
| Aug 31, 2018 | 32.51% |
| May 31, 2018 | 30.41% |
| Feb 28, 2018 | 21.81% |
| Nov 30, 2017 | -12.81% |
| Aug 31, 2017 | 41.41% |
| May 31, 2017 | 12.64% |
| Feb 28, 2017 | 11.55% |
| Nov 30, 2016 | 18.64% |
| Aug 31, 2016 | 38.36% |
| May 31, 2016 | 11.70% |
| Feb 29, 2016 | 9.10% |
| Nov 30, 2015 | 8.50% |
| Aug 31, 2015 | -17.64% |